Piper Jaffray Companies — Form 10-Q Summary
Issuer and period: The supplied filing is for Piper Jaffray Companies, not a filing under the Piper Sandler name. It covers the quarter and nine months ended September 30, 2014; financial statements are unaudited. The business operates through Capital Markets and Asset Management.
Key financial results
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Net revenues | $159.4 million | $128.3 million | $497.6 million | $337.6 million |
| Income before tax | $25.7 million | $12.1 million | $88.8 million | $33.6 million |
| Income from continuing operations attributable to Piper Jaffray Companies | $14.7 million | $6.9 million | $50.6 million | $21.9 million |
| Diluted EPS from continuing operations | $0.90 | $0.42 | $3.11 | $1.29 |
| Pre-tax operating margin | 16.1% | 9.4% | 17.9% | 9.9% |
Q3 net revenues rose 24.2%; nine-month net revenues rose 47.4%. Investment banking was the principal growth driver: Q3 revenue increased 51% to $94.9 million, led by advisory services, while nine-month investment banking revenue increased 83% to $287.2 million. Q3 institutional brokerage was nearly flat at $35.9 million; asset-management revenue increased 15.5% to $21.6 million. Nine-month expenses rose 34.4% to $408.8 million, slower than revenue growth; compensation and benefits were $300.7 million, or 60.4% of net revenues.
Segment performance: Q3 Capital Markets pre-tax income was $20.5 million versus $6.4 million a year earlier, with margin of 14.7% versus 5.8%, reflecting stronger advisory activity. Asset Management pre-tax income was $5.2 million versus $5.7 million, and margin declined to 26.2% from 31.6%. Management reported adjusted, non-GAAP Q3 diluted EPS of $1.03 versus $0.72; these measures exclude specified items, including acquisition-related compensation and intangible amortization.
Cash, balance sheet, debt, and liquidity
- At September 30, 2014, cash and cash equivalents were $14.9 million, down from $123.7 million at year-end 2013; an additional $38.0 million was segregated for regulatory purposes.
- Nine-month operating cash flow was positive $32.3 million, compared with negative $300.2 million in 2013. Investing used $5.3 million and financing used $135.7 million; cash declined $108.7 million over the period.
- Total assets were $2.60 billion and total shareholders’ equity was $945.3 million. The reported leverage ratio was 2.8x; adjusted leverage was 3.7x.
- Short-term financing was $338.8 million, down from $514.7 million at December 31, 2013. Variable-rate senior notes totaled $125 million. The notes carry floating rates and mature in 2015 and 2017; the company reported covenant compliance.
- The $250 million committed secured credit facility had no advances outstanding and was due December 27, 2014; management anticipated renewal. The company had $91 million drawn on discretionary, uncommitted bank lines.
- Broker-dealer net capital was $164.2 million. This exceeded the SEC-rule minimum by $163.2 million and was above the $120 million covenant threshold.
Changes, outlook, risks, and unusual items
- Growth was uneven across Capital Markets: Q3 advisory services revenue increased to $66.3 million from $20.2 million, while equity financing fell to $14.3 million from $30.0 million. Low equity-market volatility also weighed on equity trading activity. Fixed-income brokerage improved.
- Asset-management AUM was $12.17 billion. Value-equity AUM fell to $6.0 billion amid net outflows and quarterly market depreciation; MLP AUM reached $6.2 billion, supported by inflows and appreciation. Management cited lagging performance in some value-equity strategies as an obstacle to attracting assets.
- Management expected U.S. economic growth to improve through the rest of 2014, but anticipated challenging equity-market conditions, subdued debt underwriting, and mixed effects from potentially rising interest rates. It expected advisory services to continue performing well. No numerical earnings or revenue guidance was provided.
- Market activity, trading volumes, interest rates, credit spreads, asset values, and client flows can cause substantial period-to-period earnings variability. The company also highlighted regulatory, liquidity, counterparty, operational, and legal risks. It disclosed $25.2 million of uncollateralized derivative counterparty credit exposure, including $13.3 million to one counterparty.
- Legal claims and regulatory matters remained outstanding. Management said, based on available information and established reserves, it did not expect pending matters to have a material adverse effect, but noted potential losses could be material if circumstances change. The filing does not provide a clear aggregate reasonably possible loss estimate.
- No restructuring and integration expense was recorded in Q3 2014, compared with $3.8 million in Q3 2013. Nine-month other operating expense was $8.7 million versus $1.9 million in 2013; the comparison was affected by insurance proceeds received in 2013 for prior legal settlements and higher 2014 charitable-giving expense.
- The company reported $168.6 million of Level III fair-value assets, involving significant unobservable valuation inputs. It also had $38.0 million of private-equity investment commitments. A new $100 million share-repurchase authorization became effective October 1, 2014; the company did not repurchase shares under the prior authorization during the first nine months.
Important facts for investors to verify
- Confirm the issuer identity: this filing names Piper Jaffray Companies, although the request metadata names Piper Sandler Companies.
- Assess how much of the earnings increase depends on advisory transactions and whether that activity is sustainable.
- Review cash and funding needs, renewal of the committed facility, reliance on discretionary bank lines, and the February timing of incentive-compensation payments.
- Track value-equity outflows and investment performance alongside MLP AUM growth and market exposure.
- Evaluate derivative counterparty exposure, Level III valuations, private-equity commitments, and any developments in legal or regulatory matters.
- Distinguish GAAP results from management’s adjusted, non-GAAP measures and review the disclosed reconciliations.